AQST (Aquestive Therapeutics Inc) Net Profit

Corporate emblem and logo of aquestive.com (AQST)

This visual snapshot of Aquestive Therapeutics (AQST) price action demonstrates the impact of patents for drug-delivery films that enable strong pricing power, while the profit metric stands at -0.08. The business relies on technological superiority in drug delivery methods, which blocks the entry of new players. The company's environmental focus is centered on optimizing packaging and reducing production waste.

AQST (Aquestive Therapeutics, Inc.) Company Net Income history from 07/04/2022 to 10/31/2026

Financial and market metric breakdowns for Aquestive Therapeutics, Inc. (AQST)

- price and consensus price forecast:
Stock Quotes Aquestive Corp|AQST - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Aquestive Corp|AQST - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Aquestive Therapeutics|AQST - Company Book Value|Market-to-Book Ratio aquestive.com|AQST - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Aquestive Therapeutics|AQST - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Aquestive Therapeutics Inc|AQST - Company Aggregate Debts|Debts to Book Value Aquestive Corp|AQST - Company Long-Term Debt|Company Short-Term Loans and Borrowings Aquestive Therapeutics|Quick Ratio aquestive.com
- net income and valuation multiples indicators:
AQST - Company Net Income
Fundamental valuation:AQST Aquestive Corp
Flagship merchandise of Aquestive Therapeutics Inc

Identifying fundamentally resilient assets requires an analysis of a business's actual cash flow. This indicator captures the daily net financial result by subtracting all operating expenses from total revenue. For Aquestive Therapeutics (AQST), this metric reflects the efficiency of implementing eco-friendly thin films and the costs associated with the ESG transformation of logistics. Stable profit growth confirms the viability of the innovative drug delivery model. By analyzing the company's operating profit, an investor can identify hidden systemic risks in advance.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Net Profit TBPH (Theravance Biopharma, Inc.)|Net Profit scPharmaceuticals, Inc. SCPH|TECX - Company Net Income|Annual Net Income Tonix Pharmaceuticals Holding (TNXP)|SXTC (sxtchina.com) - Net Income|Eupraxia Pharmaceuticals Inc. (EPRX) - Net Profit|BHST (BioHarvest Sciences Inc.) - Net Profit|Company Net Income Invizyne Technologies EXOZ|Company Net Income Oramed Pharmaceuticals (ORMP)|Net Financial Result enterabio.com|MindWalk Holdings - Net Income|Profit After Payment of Taxes ABVC (abvcpharma.com)|Cumberland Pharmaceuticals Inc. - Net Profit|Net Financial Result Quantum BioPharma Ltd. QNTM|FGEN (FibroGen Corp) - Net Income|TELO (Telomir Pharmaceuticals Corp) - Company Net Income|RANI (Rani Therapeutics Holdings) - Net Profit|Company Net Income Synergy CHC Corporation SNYR|Net Income RLYB (Rallybio Corporation)|LEXX (lexariabioscience.com) - Final Profit|Pulmatrix Corp - Net Income|Profit After Payment of Taxes PTHL (Pheton Holdings Limited)|Aptorum - Net Profit|Final Profit LYRA (lyratherapeutics.com)|IBO: Net Profit|Company Net Income TNF Pharmaceuticals, Inc. (TNFA)|Company Net Income cbdMD Inc.|PRFX: Final Profit|Net Profit CYTO|Net Profit lipella.com (LIPO)|Company Net Income OptiNose OPTN|PIRS (Pieris Pharmaceuticals Inc) - Profit After Tax|Procaps Group SA - Net Profit|Company Net Income Petros Pharma|QLI (Qilian International) - Net Income|acelyrin.com (SLRN) - Net Profit|Net Income TFFP